Randomized Controlled Trial of LAIV vs TIV Vaccines in Schools (RELATIVES)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01995851|
Recruitment Status : Completed
First Posted : November 27, 2013
Last Update Posted : May 27, 2015
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||902 participants|
|Official Title:||Randomized Evaluation of Live Attenuated vs.Trivalent Inactivated Influenza Vaccines in Schools (RELATIVES)Pilot Study|
|Study Start Date :||October 2013|
|Actual Primary Completion Date :||January 2014|
|Actual Study Completion Date :||April 2014|
Healthy children and adolescents between Junior Kindergarten (JK) and Grade 8 in the intervention schools will be immunized with LAIV (FluMist influenza vaccine) recommended for the 2013-14 the influenza season.
Healthy children and adolescents between JK and Grade 8 in schools assigned to TIV will be immunized with inactivated influenza vaccine (Vaxigrip vaccine) recommended for the 2013-14 influenza season.
- Vaccine Uptake [ Time Frame: 9 Months ]
- Cost of school-based Influenza immunization clinics [ Time Frame: 9 months ]
- Incidence of laboratory-confirmed influenza [ Time Frame: 9 months ]
- Public health, parental, and school board acceptance of programs [ Time Frame: 9 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01995851
|Public Health Ontario|
|Toronto, Ontario, Canada|
|Study Director:||Scott A Halperin, MD, PhD||Nominated Principal Investigator, PHAC/CIHR Influenza Research Network (Dalhousie University)|